Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.

Literature DB >> 7793662

Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.

D Pappert¹, T Busch, H Gerlach, K Lewandowski, P Radermacher, R Rossaint.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1995 PMID： 7793662 DOI： 10.1097/00000542-199506000-00020

Source DB: PubMed Journal: Anesthesiology ISSN： 0003-3022 Impact factor: 7.892

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Improving survival in trauma patients with acute respiratory distress syndrome.

Authors: U Kaisers; T Busch
Journal: Intensive Care Med Date: 2001-07 Impact factor: 17.440

2. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?

Authors: O Eichelbrönner; H Reinelt; H Wiedeck; M Mezödy; R Rossaint; M Georgieff; P Radermacher
Journal: Intensive Care Med Date: 1996-09 Impact factor: 17.440

Review 3. Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS).

Authors: Arash Afshari; Anders Bastholm Bille; Mikkel Allingstrup
Journal: Cochrane Database Syst Rev Date: 2017-07-24

4. Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.

Authors: R Rossaint; K Lewandowski; W M Zapol
Journal: Intensive Care Med Date: 2014-09-09 Impact factor: 17.440

Review 5. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling.

Authors: A Artigas; G R Bernard; J Carlet; D Dreyfuss; L Gattinoni; L Hudson; M Lamy; J J Marini; M A Matthay; M R Pinsky; R Spragg; P M Suter
Journal: Intensive Care Med Date: 1998-04 Impact factor: 17.440

Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.

1. Improving survival in trauma patients with acute respiratory distress syndrome.

2. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?

Review 3. Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS).

4. Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.

Review 5. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling.

Review 6. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis.

Review 7. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

8. CCN1 suppresses pulmonary vascular smooth muscle contraction in response to hypoxia.

Review 9. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Review 10. Recognition and management of pulmonary hypertension.